BANDAR SERI BEGAWAN – Brunei’s Ministry of Health (MoH) has issued a public alert regarding the adulterated health product, Midos Sujin Tonmainin, manufactured by Nam King Drugs in Penang, Malaysia. Testing by the Laboratory of Pharmacy Section, Department of Scientific Services at the MoH revealed the presence of undeclared substances – specifically, Dexamethasone and Betamethasone – listed as scheduled poisons under the Poisons Act 1956. This public health concern centers on the potential for serious adverse effects from consuming a product not approved for sale in Brunei.
The discovery of these potent corticosteroids within Midos Sujin Tonmainin raises significant health risks, particularly with unsupervised or long-term use. The MoH warns that such consumption can lead to a range of complications, including increased blood glucose levels potentially resulting in diabetes, high blood pressure, cataracts, muscular and bone disorders and a heightened susceptibility to infections. Understanding the risks associated with adulterated health products is crucial for public safety, and this alert underscores the importance of verifying the authenticity and approval status of medications.
Beyond the immediate risks, prolonged use of Dexamethasone and Betamethasone can trigger Cushing’s syndrome, characterized by distinctive physical changes like a rounded face (“moon face”) and upper body obesity coupled with thinning limbs. Individuals who have been taking high doses of these steroids for an extended period may also experience withdrawal symptoms if the medication is abruptly discontinued. These symptoms can include fatigue, muscle and joint pain, fever, low blood sugar, low blood pressure, and dehydration. The MoH emphasizes the importance of seeking medical advice if anyone experiences these symptoms, especially after using this product.
What You Need to Grasp About Midos Sujin Tonmainin
The affected product, Midos Sujin Tonmainin, is manufactured by Nam King Drugs, located at 18, Kawasan Perindustrian Jelutong, Penang, Malaysia. The MoH has confirmed that it has not granted approval for the importation or sale of this product within Brunei Darussalam. The product is prohibited from being imported and sold throughout the country. This underscores the MoH’s commitment to safeguarding public health by preventing the distribution of unapproved and potentially harmful products.
Consumers who have purchased or are currently using Midos Sujin Tonmainin are strongly advised to immediately discontinue its use. The MoH urges anyone experiencing adverse effects or feeling unwell after taking the product to consult a medical practitioner without delay. Early medical intervention can help mitigate potential health complications arising from exposure to the undeclared corticosteroids.
Legal Consequences for Retailers
The MoH has issued a stern warning to those involved in the retail of this adulterated product, including those selling it online through platforms like Facebook. Selling products containing substances controlled under the Poisons Act 1956 is a criminal offense. Upon conviction, offenders face a substantial fine of BND8,000 or a prison sentence of six months.
The penalties are significantly increased for acts of negligence that endanger human life. In such cases, the fine can reach BND16,000, accompanied by a 12-month imprisonment. This highlights the serious legal ramifications associated with the sale of adulterated health products and the MoH’s determination to hold those responsible accountable.
Reporting Suspected Products
The Ministry of Health is actively seeking public cooperation in identifying and removing this product from the market. Members of the public who encounter Midos Sujin Tonmainin for sale are urged to report its presence to the Compliance and Licensing Section. This collaborative effort is vital in ensuring the swift removal of the adulterated product and protecting the health of the community.
This alert comes amid growing global concerns about the proliferation of counterfeit and adulterated medicines. Drugs.com provides comprehensive information on prescription and over-the-counter medications, offering a valuable resource for consumers seeking to verify the safety and authenticity of their medications.
Understanding Corticosteroid Risks
Dexamethasone and Betamethasone are potent corticosteroids commonly prescribed for a variety of inflammatory conditions. While effective when used appropriately under medical supervision, their unsupervised consumption carries significant risks. These risks include metabolic disturbances, immune suppression, and psychological effects. The presence of these substances in an unapproved product like Midos Sujin Tonmainin represents a serious public health hazard.
The MoH’s swift action in issuing this public alert demonstrates its commitment to protecting the health and well-being of the Bruneian population. By raising awareness about the risks associated with this adulterated product and enforcing strict regulations against its sale, the Ministry aims to prevent further harm and ensure access to safe and effective healthcare. The ongoing vigilance of both regulatory authorities and the public is essential in combating the threat of counterfeit and adulterated medicines.
The Ministry of Health will continue to monitor the situation and provide updates as necessary. Individuals seeking further information or clarification are encouraged to contact the Compliance and Licensing Section directly.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. We see essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Please share this information with your friends and family to help raise awareness about this critical public health issue. Your comments and questions are welcome below.
